University of Wisconsin Carbone Cancer Center
One of the original 1973 NCI comprehensive centres, where 5-fluorouracil was synthesised, reverse transcriptase was discovered and TomoTherapy was invented.
UW Carbone is one of the original NCI comprehensive centres (1973) and grew out of the McArdle Laboratory for Cancer Research, founded in 1940 as the first US university department devoted to cancer research. Charles Heidelberger synthesised 5-fluorouracil at McArdle in 1957; Howard Temin discovered reverse transcriptase here (Nobel Prize 1975); Rock Mackie invented TomoTherapy, the first CT-integrated intensity-modulated radiotherapy system. Paul Sondel's anti-GD2 immunotherapy programme helped establish dinutuximab for neuroblastoma through the Children's Oncology Group, and Douglas McNeel develops DNA vaccines for prostate cancer. The centre is named for Paul Carbone, long-time chair of ECOG.
- Radiation oncology (TomoTherapy heritage)
- Paediatric immunotherapy (anti-GD2)
- Prostate cancer vaccines
- Cancer biology (McArdle)
Pages like this
not linked directly; found by shared links- PersonAlice L. Yu
Shares Dinutuximab (ch14.18) / dinutuximab beta, GD2 (disialoganglioside), Children's Oncology Group (COG), Neuroblastoma (paediatric).
- TrialCOG ANBL0032
Shares Dinutuximab (ch14.18) / dinutuximab beta, GD2 (disialoganglioside), Children's Oncology Group (COG), Neuroblastoma (paediatric).
- PersonJulie R. Park
Shares Dinutuximab (ch14.18) / dinutuximab beta, GD2 (disialoganglioside), Children's Oncology Group (COG), Neuroblastoma (paediatric).
- PairingAnti-GD2 antibody + irinotecan-temozolomide (chemoimmunotherapy)
Shares Dinutuximab (ch14.18) / dinutuximab beta, GD2 (disialoganglioside), Neuroblastoma (paediatric).
- InstitutionUC San Diego Moores Cancer Center
Shares Dinutuximab (ch14.18) / dinutuximab beta, GD2 (disialoganglioside), Children's Oncology Group (COG), Neuroblastoma (paediatric).
- InstitutionSidney Kimmel Comprehensive Cancer Center at Jefferson Health
Shares Off-the-shelf cancer vaccines, Prostate cancer, Colorectal cancer.
- PairingCaution: IL-2 added to anti-GD2 therapy
Shares Dinutuximab (ch14.18) / dinutuximab beta, Neuroblastoma (paediatric).
- ProductSipuleucel-T